Hematological and pathological toxicity of anti-HER2/neu peptide mimetic modified paclitaxel bovine serum albumin nanoparticles

Journal of Chinese Pharmaceutical Sciences

Volumn 22, Issue 5, 2013, Pages 441-448

  Wang, Zhanzhang ^a   Yang, Zhenzhen ^a   Qi, Xianrong ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Albumin nanoparticle; Anti HER2 neu peptide mimetic; Paclitaxel; Target delivery; Toxicity

Indexed keywords

EID: 84885024848     PISSN: 10031057     EISSN: None     Source Type: Journal    
DOI: 10.5246/jcps.2013.05.065     Document Type: Article

References (26)

1. Crosasso, P.; Ceruti, M.; Brusa, P.; Arpicco, S.; Dosio, F.; Cattel, L. J. Control. Release. 2000, 63, 19-30.
2. Li, C.; Milas, L.; Hunter, N.R.; Ke, S.; Yu, D.F.; Charnsangavej, C.; Wallace, S. Clin. Cancer Res. 1999, 5, 891-897.
3. Sparreboom, A.; Scripture, C.D.; Trieu, V.; Williams, P.J.; De, T.; Yang, A.; Beals, B.; Figg, W.D.; Hawkins, M.; Desai, N. Clin. Cancer Res. 2005, 11, 4136-4143.
4. Kim, T.Y.; Kim, D.W.; Chung, J.Y.; Shin, S.G.; Kim, S.C.; Heo, D.S.; Kim, N.K.; Bang, Y.J. Clin. Cancer Res. 2004, 10, 3708-3716.
5. Zheng, H.; Hou, W.J.; Wang, J.C.; Zhang, Q. J. Chin. Pharm. Sci. 2012, 21, 591-597.
6. Madaan, A.; Singh, P.; Awasthi, A.; Verma, R.; Singh, A.T.; Jaggi, M.; Mishra, S.K.; Kulkarni, S.; Kulkarni, H. Clin. Transl. Oncol. 2013, 15, 26-32.
7. Hoffman, A.S. J. Control. Release. 2008, 132, 153-163.
8. Azarmi, S.; Roa, W.H.; Löbenberg, R. Adv. Drug Deliv. Rev. 2008, 60, 863-875.
9. Owens, D.E.; Peppas, N.A. Int. J. Pharm. 2006, 307, 93-102.
10. Aqil, F.; Munagala, R.; Jeyabalan, J.; Vadhanam, M.V. Cancer Lett. 2013, 334, 133-141.
11. Desai, N.P.; Louie, L.; SoonShiong, P.; Tao, C.L.; Yang, A. U.S. Pat. 8137684, 2006; A61K31/337.
12. Park, B.W.; Zhang, H.T.; Wu, C.; Berezov, A.; Zhang, X.; Dua, R.; Wang, Q.; Kao, G.; O'Rourke, D.M.; Greene, M.I.; Murali, R. Nat. Biotechnol. 2000, 18, 194-198.
13. Weber, C.; Coester, C.; Kreuter, J.; Langer, K. Int. J. Pharm. 2000, 194, 91-102.
14. Langer, K.; Balthasar, S.; Vogel, V.; Dinauer, N.; von Briesen, H.; Schubert, D. Int. J. Pharm. 2003, 257, 169-180.
15. Orsi, I.A.; Andrade, V.G.; Bonato, P.S.; Raimundo, L.B.; Herzog, D.S.; Borie, E. Braz. Dent. J. 2011, 22, 490-496.
16. Guillemard, V.; Nedev, H.N.; Berezov, A.; Murali, R.; Saragovi, H.U. DNA Cell Biol. 2005, 24, 351-358.
17. Dunphy, F.R.; Dunleavy, T.L.; Harrison, B.R.; Boyd, J.H.; Varvares, M.A.; Dunphy, C.H.; Rodriguez, J.J.; McDonough, E.M.; Minster, J.R.; McGrady, M.D. Cancer. 1997, 79, 1623-1628.
18. Fetterly, G.J.; Tamburlin, J.M.; Straubinger, R.M. Biopharm. Drug Dispos. 2001, 22, 251-261.
19. Groopman, J.E.; Itri, L.M. J. Natl. Cancer Inst. Monographs. 1999, 91, 1616-1634.
20. Arunachalam, B.; Phan, U.T.; Geuze, H.J.; Cresswell, P. Proc. Natl. Acad. Sci. USA. 2000, 97, 745-750.
21. Desai, N.; Trieu, V.; Yao, Z.; Louie, L.; Ci, S.; Yang, A.; Tao, C.; De, T.; Beals, B.; Dykes, D.; Noker, P.; Yao, R.; Labao, E.; Hawkins, M.; SoonShiong, P. Clin. Cancer Res. 2006, 12, 1317-1324.
22. Marceau, P.; Biron, S.; Hould, F.S.; Marceau, S.; Simard, S.; Thung, S.N.; Kral, J.G. J. Clin. Endocrinol. Metab. 1999, 84, 1513-1517.
23. Gwinn, M.R.; Vallyathan, V. Environ. Health Perspect. 2006, 114, 1818-1825.
24. Pourmand, A.; Abdollahi, M. Daru. 2012, 20, 95.
25. Mostafalou, S.; Mohammadi, H.; Ramazani, A.; Abdollahi, M. Daru. 2013, 21, 1-4.
26. Hagens, W.I.; Oomen, A.G.; de Jong, W.H.; Cassee, F.R.; Sips, A.J. Regul. Toxicol. Pharmacol. 2007, 49, 217-229.